Repros Therapeutics Inc.
RPRX
RPRX was delisted on the 31st of January, 2018.
81 hedge funds and large institutions have $414M invested in Repros Therapeutics Inc. in 2013 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
23% less call options, than puts
Call options by funds: $35.1M | Put options by funds: $45.3M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
76
Tower Research Capital (TRC)
New York
| $21K | +$20.3K | +1,149 | New |
|
77
Bank of Montreal
Toronto,
Ontario, Canada
| $18K | +$17.7K | +1,000 | New |
|
78
BlackRock
New York
| $9K | +$8.76K | +496 | New |
|
|
LTFS
79
Ladenburg Thalmann Financial Services
Miami,
Florida
| $7K | +$7.06K | +400 | New |
|
|
KTC
80
Kistler-Tiffany Companies
Berwyn,
Pennsylvania
| $5K | +$4.77K | +270 | New |
|
81
Wells Fargo
San Francisco,
California
| – | +$18 | +1 | New |
|
RPRX Hedge Fund Activity: Q2 2013 in Review
81 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q2 2013, worth a combined $414M.
Buyers outnumbered sellers: 81 funds opened new RPRX positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.
- 81 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $414M of Repros Therapeutics Inc. stock for Q2 2013.
- 81 funds opened new Repros Therapeutics Inc. positions in Q2 2013 and 0 closed out, a net change of +81 holders.
Based on aggregated 13F filings for Q2 2013.